232,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
116 °P sammeln
  • Gebundenes Buch

Dietary sugars, fructose in particular, have potential roles in obesity and metabolic diseases. This book is the first comprehensive treatment presenting all aspects of dietary sugars as they relate to health and disease, from historical perspectives to public health policies. Sections focus on the classification and production of sugars, social and economic aspects of sugars, physiology and metabolism of dietary sugars, and sugar and public health. Each chapter features a concise, thorough summary of current knowledge, including an overview of cutting-edge research, controversies, and future perspectives.…mehr

Produktbeschreibung
Dietary sugars, fructose in particular, have potential roles in obesity and metabolic diseases. This book is the first comprehensive treatment presenting all aspects of dietary sugars as they relate to health and disease, from historical perspectives to public health policies. Sections focus on the classification and production of sugars, social and economic aspects of sugars, physiology and metabolism of dietary sugars, and sugar and public health. Each chapter features a concise, thorough summary of current knowledge, including an overview of cutting-edge research, controversies, and future perspectives.
Autorenporträt
Michael I. Goran is a professor of preventive medicine and pediatrics at the University of Southern California in Los Angeles. He is also the founding director of the USC Childhood Obesity Research Center and holds the Dr. Robert C and Veronica Atkins Endowed Chair in Childhood Obesity and Diabetes. In addition, he serves as co-director of the USC Diabetes and Obesity Research Institute. He received his PhD from the University of Manchester in the UK. His work focuses on understanding the metabolic and nutritional factors linking obesity to increased disease risk during growth and development and using this information as a basis for developing interventions for prevention and risk reduction. He has published more than 300 peer-reviewed scientific articles and reviews and is the co-editor of the Handbook of Pediatric Obesity. Luc Tappy is a professor of physiology at the University of Lausanne in Switzerland and an associate physician in endocrinology, diabetes, and metabolism at Lausanne University Hospital. He has extensively studied the metabolic fate of fructose in healthy humans and in patients with metabolic disorders with the use of tracer methods. As a physician, he has been mainly involved in the dietary management and surgical treatment of obese patients. His research has been mainly supported by grants from the Swiss National Science Foundation and other funders. Kim-Anne Lê is a research scientist at the Nestlé Research Center in Vers-chez-les Blanc, Switzerland. She obtained her PhD from the University of Lausanne and completed a postdoctoral fellowship at the Childhood Obesity Research Center in USC Los Angeles. For the past ten years she has been studying the effects of sugars and fructose on cardiometabolic risk markers. She has received research support from the Swiss National Foundation for Science for these activities.